Pathophysiology and Treatment Considerations for Erosive Pustular Dermatosis
Omer Ibrahim, Kenneth A. Arndt, Jeffrey S. Dover
págs. 971-972
Uniform Nomenclature to Describe Clinical Features of Pigmented Lesions
Kelsey S. Flood, Gary J. Martin, June K. Robinson
págs. 973-975
Noninvasive Testing for Nonalcoholic Steatohepatitis and Hepatic Fibrosis in Patients With Psoriasis Receiving Long-term Methotrexate Sodium Therapy
Bruce Bauer, Po-Huang Chyou, Erik J. Stratman
págs. 977-982
Association of Vitamin D Receptor Polymorphisms With the Risk of Nonmelanoma Skin Cancer in Adults
Erin M. Burns, Purushotham Guroji, Israr Ahmad
págs. 983-989
Factors in Early Adolescence Associated With a Mole-Prone Phenotype in Late Adolescence
Haoxing Xu, Michael A. Marchetti, Stephen W. Dusza
págs. 990-998
Genotypic and Phenotypic Features of BAP1 Cancer SyndromeA Report of 8 New Families and Review of Cases in the Literature
Alexandra M. Haugh, Ching-Ni Njauw, Jeffrey A. Bubley
págs. 999-1006
Identifying an Optimal Adjuvant Radiotherapy Dose for Extremity and Trunk Merkel Cell Carcinoma Following ResectionAn Analysis of the National Cancer Database
Sagar A. Patel, Muhammad M. Qureshi, Debjani Sahni
págs. 1007-1014
Low-Dose Naltrexone Treatment of Familial Benign Pemphigus (Hailey-Hailey Disease)
Omer Ibrahim, Sara R. Hogan, Alok Vij
págs. 1015-1017
Treatment of Hailey-Hailey Disease With Low-Dose Naltrexone
Lauren N. Albers, Jack L. Arbiser, Ron J. Feldman
págs. 1018-1020
Facial Erosive Pustular Dermatosis After Cosmetic Resurfacing
Julie E. Mervak, Stephanie D. Gan, Emily H. Smith
págs. 1021-1025
Association of Incident Amelanotic Melanoma With Phenotypic Characteristics, MC1R Status, and Prior Amelanotic Melanoma
Steven Vernali, Weston T. Waxweiler, Patrick M. Dillon
págs. 1026-1031
© 2001-2024 Fundación Dialnet · Todos los derechos reservados
Coordinado por: